Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases

Almirall S.A. and Absci Corporation announced a drug discovery partnership aimed to develop and commercialize AI-designed therapeutics to fight chronic and debilitating dermatological diseases.